{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-156048","form_type":"8-K","ticker":"TNGX","cik":"0001819133","company_name":"Tango Therapeutics, Inc.","filed_at":"2024-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.341540+00:00","generated_at":"2026-06-01T05:59:15.656873+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Tango Therapeutics stockholders approve officer liability limit and elect directors at 2024 annual meeting","bullets":["Shareholders approved amendment to Second Amended and Restated Certificate of Incorporation to limit officer liability under Delaware law (89.9M for, 5.5M against).","Elected Alexis Borisy, John Ketchum, and Barbara Weber as Class III directors each with >90M votes for.","Ratified PricewaterhouseCoopers as independent auditor for FY2024 (100.7M for, 2K against).","Quorum of 94.35% (100.7M shares) present at virtual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-156048","json":"https://secwatch.observer/filing/0001193125-24-156048.json","markdown":"https://secwatch.observer/filing/0001193125-24-156048.md","text":"https://secwatch.observer/filing/0001193125-24-156048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819133/000119312524156048/0001193125-24-156048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819133/000119312524156048/d768398d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:59:15.656873+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}